<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8004872</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1436</journal-id>
<journal-id journal-id-type="nlm-ta">Behav Brain Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Behav. Brain Res.</journal-id>
<journal-title-group>
<journal-title>Behavioural brain research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0166-4328</issn>
<issn pub-type="epub">1872-7549</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28964912</article-id>
<article-id pub-id-type="pmc">5645257</article-id>
<article-id pub-id-type="doi">10.1016/j.bbr.2017.09.043</article-id>
<article-id pub-id-type="manuscript">NIHMS911481</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional Coding Variation in the Presynaptic Dopamine Transporter Associated with Neuropsychiatric Disorders Drives Enhanced Motivation and Context-Dependent Impulsivity in Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Davis</surname>
<given-names>Gwynne L.</given-names>
</name>
<!--<email>davisg@health.fau.edu</email>-->
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stewart</surname>
<given-names>Adele</given-names>
</name>
<degrees>Ph.D.</degrees>
<!--<email>stewarta@health.fau.edu</email>-->
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stanwood</surname>
<given-names>Gregg D.</given-names>
</name>
<degrees>Ph.D.</degrees>
<!--<email>gregg.stanwood@med.fsu.edu</email>-->
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gowrishankar</surname>
<given-names>Raajaram</given-names>
</name>
<!--<email>rgowrishankar@health.fau.edu</email>-->
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hahn</surname>
<given-names>Maureen K.</given-names>
</name>
<degrees>Ph.D.</degrees>
<!--<email>hahnm@health.fau.edu</email>-->
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blakely</surname>
<given-names>Randy D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Pharmacology, Vanderbilt University, 2220 Pierce Ave, Nashville, TN 37232</aff>
<aff id="A2">
<label>2</label>Department of Biomedical Science, Charles E. Schmidt College of Medicine</aff>
<aff id="A3">
<label>3</label>Brain Institute, Florida Atlantic University, 5353 Parkside Drive, Jupiter, FL 33458</aff>
<aff id="A4">
<label>4</label>Biomedical Sciences, Florida State University College of Medicine, 1115 West Call Street, Tallahassee, FL, 32306</aff>
<author-notes>
<corresp id="FN1"><bold>Correspondence:</bold> Randy D. Blakely, Ph.D., Florida Atlantic University, FAU Brain Institute, Room 109 MC-17, 5353 Parkside Drive, Jupiter, FL 33458, TEL: 561-799-8100; <email>rblakely@fau.edu</email>; web: <ext-link ext-link-type="uri" xlink:href="www.blakelylab.org">www.blakelylab.org</ext-link></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>30</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>337</volume>
<fpage>61</fpage>
<lpage>69</lpage>
<!--elocation-id from pubmed: 10.1016/j.bbr.2017.09.043-->
<abstract>
<p id="P1">Recent genetic analyses have provided evidence that clinical commonalities associated with different psychiatric diagnoses often have shared mechanistic underpinnings. The development of animal models expressing functional genetic variation attributed to multiple disorders offers a salient opportunity to capture molecular, circuit and behavioral alterations underlying this hypothesis. In keeping with studies suggesting dopaminergic contributions to attention-deficit hyperactivity disorder (ADHD), bipolar disorder (BPD) and autism spectrum disorder (ASD), subjects with these diagnoses have been found to express a rare, functional coding substitution in the dopamine (DA) transporter (DAT), Ala559Val. We developed DAT Val559 knock-in mice, as a construct valid model of dopaminergic alterations that drive multiple clinical phenotypes, and here evaluate the impact of lifelong expression of the variant on impulsivity and motivation, utilizing the 5-choice serial reaction time task (5-CSRTT) and Go/NoGo as well as tests of time estimation (peak interval analysis), reward salience (sucrose preference), and motivation (progressive ratio test). Our findings indicate that the DAT Val559 variant induces impulsivity behaviors that are dependent upon the reward context, with increased impulsive action observed when mice are required to delay responding for a reward, whereas mice are able to withhold responding if there is a probability of reward for a correct rejection. Utilizing peak interval and progressive ratio tests, we provide evidence that impulsivity is likely driven by an enhanced motivational phenotype that also may drive faster task acquisition in operant tasks. These data provide critical validation that DAT, and more generally, DA signaling perturbations can drive impulsivity that can manifest in specific contexts and not others, and may rely on motivational alterations which may also drive increased maladaptive reward seeking.</p>
</abstract>
<kwd-group>
<kwd>Attention-Deficit Hyperactivity Disorder</kwd>
<kwd>Motivation</kwd>
<kwd>Impulsivity</kwd>
<kwd>Dopamine Transporter</kwd>
<kwd>Transgenic Model</kwd>
<kwd>Instrumental Learning</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>